Towards Healthcare

Cell Therapy Manufacturing Key Players | Innovation and Product Evolution | Market Entry and Expansion Strategies | Investment and Capital Allocation | Technology Commercialization | Market Trends Analysis | Future Market Positioning

Date: January 2025

Cell Therapy Manufacturing Key Players-Business, Deal & Patent Strategies

The global cell therapy manufacturing market is estimated to grow from USD 3.92 billion in 2022 at 16% CAGR (2023-2032) to reach an estimated USD 16.40 billion by 2032.

Cell Therapy Manufacturing Top Companies

  • Merck KGaA
  • Thermo Fisher Scientific
  • Catalent, Inc
  • Bio-Techne
  • Cytiva
  • Lonza
  • The Discovery Labs
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.

US Import Data for Cell Culture Media, Biological Reagents, Cryopreservation Equipment, and Medical Equipment for Cell Processing

Consignee Name Shipper Name Loading Port Unloading Port Sum of Quantity Sum of Weight (kg)
Fisher and Paykel Healthcare USA KY Fisher and Paykel Healthcare Limited 61443, Tauranga 1601, Charleston, SC 2,805,193 1,359,735
Cerus Corp Cerus Europe B V 42157, Rotterdam 1401, Norfolk, VA 990,576 363,172
Eucatex of North America Inc Eucatex Industria e Comercio Ltd. 35177, Sao Paulo 1303, Baltimore, MD 901,730 5,319,866,664
Eucatex of North America Inc Eucatex Industria e Comercio Ltd. 35177, Sao Paulo 1805, Fernandina Beach, FL 796,910 2,646,641,799
Fisher and Paykel Healthcare USA KY Fisher and Paykel Healthcare Limited 61443, Tauranga 1401, Norfolk, VA 1,632,720 492,769